Squarepoint’s iRadimed IRMD Stock Holding History

Squarepoint’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$422K	Buy	+4,389	New	+$439K	﹤0.01%	3432
2025 Q1	–	Sell	-15,764	Closed	-$867K	–	4996
2024 Q4	$867K	Buy	15,764 +4,591	+41%	+$242K	﹤0.01%	3191
2024 Q3	$562K	Sell	11,173 -10,622	-49%	-$490K	﹤0.01%	3008
2024 Q2	$958K	Buy	21,795 +9,343	+75%	+$397K	﹤0.01%	2582
2024 Q1	$548K	Buy	+12,452	New	+$550K	﹤0.01%	2981
2020 Q2	–	Sell	-13,670	Closed	-$292K	–	2365
2020 Q1	$292K	Sell	13,670 -14,634	-52%	-$348K	0.01%	1313
2019 Q4	$662K	Buy	28,304 +14,672	+108%	+$343K	﹤0.01%	1595
2019 Q3	$287K	Buy	+13,632	New	+$278K	﹤0.01%	1924

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's IRMD Position: Q1 2026 in Review

Squarepoint opened a new position in iRadimed (IRMD) in Q1 2026: 4,389 shares worth $422K. The stake represents ﹤0.01% of the portfolio and ranks #3432 among its holdings. This is a return to the name: Squarepoint previously reported a position in IRMD as recently as Q4 2024.

Squarepoint first reported a position in IRMD in Q3 2019 and has held it in 8 quarters since. The position peaked at $958K in Q2 2024. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Squarepoint held 4,389 shares of iRadimed worth $422K as of Q1 2026.
iRadimed was a new Squarepoint position in Q1 2026.
iRadimed made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3432 holding.
Squarepoint first reported a position in iRadimed in Q3 2019 and has held it in 8 quarters since.
Squarepoint's iRadimed position peaked at $958K in Q2 2024.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.